Search Results - "Runken, M. Chris"

Refine Results
  1. 1

    Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study by Podger, Lauren, Stewart, Walter F, Serrano, Daniel, Lipton, Richard B, Gomez-Ulloa, David, Ayasse, Nicolai D, Barnes, Frederick B, Davis, E Anne, Runken, M Chris

    Published in Journal of Alzheimer's disease (02-04-2024)
    “…A theoretical endpoint staging framework was previously developed and published, aligning outcomes (i.e., memory) to the stage of Alzheimer's disease (AD) in…”
    Get more information
    Journal Article
  2. 2

    Evaluation of Physician-Patient Interactions Regarding Route of Administration for Immunoglobulin Therapy in Primary Immunodeficiency Disease by Wasserman, Dan, Runken, M. Chris, PharmD, Wells, Michael, PharmD Candidate

    Published in Journal of allergy and clinical immunology (01-02-2017)
    “…Methods We conducted IRB-approved online surveys with 100 board-certified allergists/immunologists treating PIDD patients, and 158 PIDD patients currently…”
    Get full text
    Journal Article
  3. 3

    Patient and Physician-interpreted Patient Preferences for Administration of Immunoglobulin Therapy in Primary Immunodeficiency Disorder by Runken, M. Chris, PharmD, Wasserman, Dan, Wells, Michael, PharmD

    Published in Journal of allergy and clinical immunology (01-02-2017)
    “…Rationale The routes of administration (RoA) of immunoglobulin(IG) therapy for primary immunodeficiency disorder(PIDD) have many differentiating…”
    Get full text
    Journal Article
  4. 4

    Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregivers by Gómez-Ulloa, David, Runken, M Chris, Rodriguez, Wilton I, Hernández, Basilio, Chivite, Montserrat, Davis, E Anne, Nisbet, Paul

    Published in Drugs in Context (29-04-2024)
    “…As research continues towards improved treatments for Alzheimer disease (AD), there is growing interest in the views and needs from patients and caregivers on…”
    Get full text
    Journal Article
  5. 5

    The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research by Burton, Wayne N., Landy, Stephen H., Downs, Kristen E., Runken, M. Chris

    Published in Mayo Clinic proceedings (01-05-2009)
    “…Evidence suggests that migraine is associated with decreased productivity. This article describes the results of a systematic literature review of…”
    Get full text
    Journal Article
  6. 6

    Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain by Runken, M. Chris, Caraceni, Paolo, Fernandez, Javier, Zipprich, Alexander, Carlton, Rashad, Bunke, Martin

    Published in Health economics review (17-04-2020)
    “…Following publication of the original article [1], the authors reported that one of the numbers within Fig. 6 contains a mistake…”
    Get full text
    Journal Article
  7. 7

    Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database Analysis by Guptill, Jeffrey T, Runken, M Chris, Eaddy, Michael, Lunacsek, Orsolya, Fuldeore, Rupali M

    Published in American health & drug benefits (01-05-2019)
    “…Corticosteroids, plasma exchange, and intravenous immunoglobulin (IVIG) have been standard-of-care treatments for chronic inflammatory demyelinating…”
    Get full text
    Journal Article
  8. 8

    The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain by Runken, M. Chris, Caraceni, Paolo, Fernandez, Javier, Zipprich, Alexander, Carlton, Rashad, Bunke, Martin

    Published in Health economics review (05-07-2019)
    “…Background: Albumin is frequently prescribed in cirrhotic patients with acute decompensation. However, the true cost effectiveness of albumin use in cirrhotic…”
    Get full text
    Journal Article
  9. 9

    Examining the Interrelationship of Migraine Onset, Duration, and Time to Treatment by Landy, Stephen H., Runken, M. Chris, Bell, Christopher F., Higbie, Rachel L., Haskins, Lisa S.

    Published in Headache (01-03-2012)
    “…Objective.— The objective of this study is to investigate migraines, both longitudinally and cross‐sectionally, to understand the impact that time of treatment…”
    Get full text
    Journal Article
  10. 10

    Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG? by Allen, Jeffrey A., Gelinas, Deborah F., Freimer, Miriam, Runken, M. Chris, Wolfe, Gil I.

    Published in Journal of the neurological sciences (15-01-2020)
    “…Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired neurological disorder characterized clinically by weakness and impaired sensory…”
    Get full text
    Journal Article
  11. 11

    The Development of a Survey to Measure Completeness of Response to Migraine Therapy by Coon, Cheryl D., Fehnel, Sheri E., Davis, Kimberly H., Runken, M. Chris, Beach, M. E., Cady, Roger K.

    Published in Headache (01-04-2012)
    “…Objective.— To assess the psychometric properties of a new patient‐reported migraine instrument, the Completeness of Response Survey (CORS), which measures a…”
    Get full text
    Journal Article
  12. 12

    The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy by Bril, Vera, Blanchette, Christopher M, Noone, Joshua M, Runken, M. Chris, Gelinas, Deborah, Russell, James W

    Published in Journal of diabetes and its complications (01-09-2016)
    “…Abstract Purpose We reviewed the literature on chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetes mellitus (DM) and explored real-world data…”
    Get full text
    Journal Article
  13. 13

    Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study by Lipton, Richard B., Serrano, Daniel, Nicholson, Robert A., Buse, Dawn C., Runken, M. Chris, Reed, Michael L.

    Published in Headache (01-11-2013)
    “…Objectives To assess the influence of triptan or nonsteroidal anti‐inflammatory drug (NSAID) use on the likelihood of developing chronic migraine (CM) among…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine by Derosier, Frederick J, Lewis, Donald, Hershey, Andrew D, Winner, Paul K, Pearlman, Eric, Rothner, Arnold David, Linder, Steven L, Goodman, David K, Jimenez, Theresa B, Granberry, Wendy K, Runken, M Chris

    Published in Pediatrics (Evanston) (01-06-2012)
    “…Treatment of adolescent migraine remains a significant unmet medical need. We compared the efficacy and safety of 3 doses of sumatriptan and naproxen sodium…”
    Get full text
    Journal Article
  16. 16

    The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research by Burton, Wayne N., MD, Landy, Stephen H., MD, Downs, Kristen E., MSPH, Runken, M. Chris, PharmD

    Published in Mayo Clinic proceedings (2009)
    “…Evidence suggests that migraine is associated with decreased productivity. This article describes the results of a systematic literature review of…”
    Get full text
    Journal Article
  17. 17

    Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US by Sandhaus, Robert, Strange, Charlie, Stone, Glenda, Runken, M. Chris, Blanchette, Christopher M, Howden, Reuben

    “…Introduction: Alpha-1 antitrypsin deficiency (AATD) is often not identified in patients with chronic obstructive pulmonary disease (COPD) until advanced stages…”
    Get full text
    Journal Article
  18. 18

    Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States by Neufeld, Ellis J, Sidonio, Jr, Robert F, O'Day, Ken, Runken, M Chris, Meyer, Kellie, Spears, Jeffrey

    Published in Journal of medical economics (03-08-2018)
    “…Inhibitor development to factor VIII (FVIII) hemophilia therapy results in increased complications and substantial economic costs. The SIPPET study, the first…”
    Get more information
    Journal Article
  19. 19

    Consistency of Return to Normal Function, Productivity, and Satisfaction Following Migraine Attacks Treated With Sumatriptan/Naproxen Sodium Combination by Landy, Stephen H., Cady, Roger K., Nelsen, Andrew, White, Jonathan, Runken, M. Chris

    Published in Headache (01-04-2014)
    “…Objectives To assess the consistency of improved functioning, productivity, and medication satisfaction in migraines treated with a single tablet of…”
    Get full text
    Journal Article
  20. 20

    A Cross-Sectional Survey to Assess the Migraineur's Medication Decision-Making Beliefs: Determining When a Migraine Is Triptan-Worthy by Landy, Stephen H., Turner, Ira M., Runken, M. Chris, Lee, Mechele, Sulcs, Ellen, Bell, Christopher F.

    Published in Headache (01-07-2013)
    “…Objectives To investigate the factors that influence a migraineur's beliefs regarding oral triptans for the acute treatment of migraines and to provide further…”
    Get full text
    Journal Article